Jean-Michel Chezal Selected Research

Jean-Michel Chezal Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 06/2008
28	Melanoma (Melanoma, Malignant) 04/2022 - 06/2008
11	Chondrosarcoma 06/2022 - 09/2009
5	Hypoxia (Hypoxemia) 01/2021 - 01/2017
4	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2020
3	Diarrhea 05/2016 - 10/2007
2	Extraskeletal Myxoid Chondrosarcoma 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2015 - 10/2014
1	Cholangiocarcinoma 06/2022
1	Glioma (Gliomas) 06/2022
1	Tics (Tic) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Circulating Neoplastic Cells 11/2019
1	Peritoneal Neoplasms 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 03/2017
1	Hepatitis C 05/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016
1	Inflammation (Inflammations) 05/2015
1	Pain (Aches) 05/2015
1	Arthritis (Polyarthritis) 05/2015
1	Rheumatoid Arthritis 05/2015

Drug/Important Bio-Agent (IBA)

19	Melanins (Melanin)IBA 04/2022 - 08/2008
17	Radioisotopes (Radionuclides)IBA 11/2023 - 06/2008
12	N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamideIBA 04/2022 - 11/2008
10	Proteoglycans (Proteoglycan)IBA 01/2020 - 09/2009
9	LigandsIBA 11/2023 - 11/2011
9	ProdrugsIBA 01/2023 - 05/2011
5	Ammonium CompoundsIBA 01/2020 - 11/2014
4	Idoxuridine (Stoxil)FDA LinkGeneric 09/2016 - 10/2013
3	AntigensIBA 01/2024 - 01/2021
3	pyridineIBA 01/2022 - 05/2010
3	Iodine-125IBA 09/2016 - 05/2013
3	Peptides (Polypeptides)IBA 02/2015 - 11/2011
3	AcridinesIBA 08/2014 - 08/2008
2	EnzymesIBA 04/2024 - 06/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 12/2022
2	benzamideIBA 04/2022 - 11/2011
2	ICF05016IBA 01/2021 - 01/2020
2	azomycinIBA 01/2020 - 11/2017
2	Aggrecans (Aggrecan)IBA 01/2020 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 03/2017
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2017 - 11/2014
2	IodineIBA 03/2016 - 11/2013
2	QuinoxalinesIBA 05/2014 - 08/2009
2	N- (2- (diethylamino)ethyl)- 4- iodobenzamideIBA 11/2011 - 06/2008
1	Tryptophan (L-Tryptophan)FDA Link 04/2024
1	human ERBB2 proteinIBA 01/2024
1	Ado-Trastuzumab EmtansineIBA 01/2024
1	auristatinIBA 01/2024
1	Contrast MediaIBA 11/2023
1	Netrin-1IBA 11/2023
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2023
1	Antimitotic AgentsIBA 01/2023
1	isocitric acid (isocitrate)IBA 06/2022
1	SolutionsIBA 06/2022
1	Oxidoreductases (Dehydrogenase)IBA 06/2022
1	hydroxide ionIBA 01/2022
1	copper(I) triflateIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Organotin CompoundsIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	fluoromisonidazoleIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	imidazoleIBA 01/2020
1	procaine isothiocyanate (PRIT)IBA 01/2019
1	Alkylating AgentsIBA 11/2017
1	phosphoramidic acidIBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Chlorambucil (Leukeran)FDA Link 10/2017
1	Doxycycline (Periostat)FDA LinkGeneric 09/2017
1	Matrix Metalloproteinase InhibitorsIBA 09/2017
1	TetraspaninsIBA 03/2017
1	TH 302IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	GlycosaminoglycansIBA 01/2017
1	PolymersIBA 01/2017
1	pimonidazoleIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	TritiumIBA 11/2016
1	Subgenomic RNAIBA 05/2016
1	3- (imidazo(1,2- a- 5,4- b')dipyridin- 2- yl)anilineIBA 05/2016
1	aniline (aniline hydrobromide)IBA 05/2016
1	Cyclic NucleotidesIBA 04/2016
1	A-Form DNA (A-DNA)IBA 03/2016
1	Glutathione (Reduced Glutathione)IBA 08/2015
1	DisulfidesIBA 08/2015
1	Freund's AdjuvantIBA 05/2015
1	Meloxicam (Mobic)FDA LinkGeneric 05/2015

Therapy/Procedure

26	Therapeutics 11/2023 - 06/2008
7	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
5	Radiotherapy 11/2023 - 06/2008
3	Radioimmunotherapy 10/2020 - 03/2017
2	Precision Medicine 10/2020 - 01/2017
2	Intravenous Injections 03/2015 - 04/2013
1	Neoadjuvant Therapy 01/2020
1	Immunotherapy 03/2017